BACKGROUND: Prior work has related elevated life stress to greater risk of cervical neoplasia in women with human immunodeficiency virus (HIV) and human papillomavirus (HPV). PURPOSE: This study investigated associations between depressive symptoms and cervical neoplasia in HIV+ HPV+ women. Participants were 58 HIV+ HPV+ women. METHOD: Participants underwent colposcopy, including HPV screening, Papanicolaou smear, and cervical biopsy to determine study eligibility. Eligible participants completed the Beck Depression Inventory (BDI) and the Center for Epidemiologic Studies-Depression (CES-D) scale. RESULTS: Presence and severity of clinically significant depressive symptomatology were associated with cervical neoplasia. Hierarchical logistic regression analysis revealed that women with greater depressive symptoms had marginally greater odds of presenting with cervical neoplasia (BDI: OR = 1.16, p = 0.092; CES-D: OR = 1.15, p = 0.067. Women with greater somatic depressive symptoms, specifically, had significantly greater odds of presenting with cervical neoplasia (BDI: OR = 1.86, p = 0.027; CES-D: OR = 1.56, p = 0.017). CONCLUSION: These findings suggest that screening HIV+ women for somatic depression may help identify those at risk for cervical neoplasia. Future depression research with medical populations should discern somatic depressive symptoms from disease symptoms, as they may have important value in independently predicting health outcomes.
BACKGROUND: Prior work has related elevated life stress to greater risk of cervical neoplasia in women with human immunodeficiency virus (HIV) and human papillomavirus (HPV). PURPOSE: This study investigated associations between depressive symptoms and cervical neoplasia in HIV+ HPV+ women. Participants were 58 HIV+ HPV+ women. METHOD:Participants underwent colposcopy, including HPV screening, Papanicolaou smear, and cervical biopsy to determine study eligibility. Eligible participants completed the Beck Depression Inventory (BDI) and the Center for Epidemiologic Studies-Depression (CES-D) scale. RESULTS: Presence and severity of clinically significant depressive symptomatology were associated with cervical neoplasia. Hierarchical logistic regression analysis revealed that women with greater depressive symptoms had marginally greater odds of presenting with cervical neoplasia (BDI: OR = 1.16, p = 0.092; CES-D: OR = 1.15, p = 0.067. Women with greater somatic depressive symptoms, specifically, had significantly greater odds of presenting with cervical neoplasia (BDI: OR = 1.86, p = 0.027; CES-D: OR = 1.56, p = 0.017). CONCLUSION: These findings suggest that screening HIV+ women for somatic depression may help identify those at risk for cervical neoplasia. Future depression research with medical populations should discern somatic depressive symptoms from disease symptoms, as they may have important value in independently predicting health outcomes.
Authors: A Bennetts; L Irwig; B Oldenburg; J M Simpson; P Mock; A Boyes; K Adams; E Weisberg; J Shelley Journal: J Clin Epidemiol Date: 1995-10 Impact factor: 6.437
Authors: Sheri D Weiser; Elise D Riley; Kathleen Ragland; Gwendolyn Hammer; Richard Clark; David R Bangsberg Journal: J Gen Intern Med Date: 2006-01 Impact factor: 5.128
Authors: Deidre Byrnes Pereira; Michael H Antoni; Aimee Danielson; Trudi Simon; JoNell Efantis-Potter; Charles S Carver; Ron E F Durán; Gail Ironson; Nancy Klimas; Mary Ann Fletcher; Mary Jo O'Sullivan Journal: J Psychosom Res Date: 2003-03 Impact factor: 3.006
Authors: D M Byrnes; M H Antoni; K Goodkin; J Efantis-Potter; D Asthana; T Simon; J Munajj; G Ironson; M A Fletcher Journal: Psychosom Med Date: 1998 Nov-Dec Impact factor: 4.312
Authors: Deidre Byrnes Pereira; Michael H Antoni; Aimee Danielson; Trudi Simon; JoNell Efantis-Potter; Charles S Carver; Ron E F Durán; Gail Ironson; Nancy Klimas; Mary Jo O'Sullivan Journal: Psychosom Med Date: 2003 May-Jun Impact factor: 4.312
Authors: James R Hébert; Kathryn L Braun; Joseph Keawe'aimoku Kaholokula; Cheryl A Armstead; James B Burch; Beti Thompson Journal: Prog Community Health Partnersh Date: 2015